A possible case of L-carnitine-responsive cardiomyopathy in a Boxer

Australian Veterinary Practitioner

Volumn 32, Issue 2, 2002, Pages 55-59

  Frater, Julanne L ^a  

^a NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BENAZEPRIL; CARNITINE; DIGOXIN; FUROSEMIDE;

ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE COURSE; DOG; ECHOCARDIOGRAPHY; FEMALE; NONHUMAN; PROGNOSIS; VITAMIN SUPPLEMENTATION;

EID: 0036600277     PISSN: 0310138X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Case report: Efficacy of oral L-carnitine therapy for dilated cardiomyopathy in Boxer dogs
2. Canine dilated cardiomyopathy 1. Breed manifestations and diagnosis
3. Boxer cardiomyopathy - A review of the long term benefits of antiarrhythmic therapy
4. L-carnitine supplementation in the therapy of canine dilated cardiomyopathy
5. Carnitine supplementation: What have we learned?
6. Myocardial L-carnitine deficiency in a family of dogs with dilated cardiomyopathy
7. Results of the Multicenter Spaniel Trial (MUST): Taurine- and carnitine-responsive dilated cardiomyopathy in American Cocker Spaniels with decreased plasma taurine concentration
8. Myocardial carnitine metabolism in congestive heart failure induced by incessant tachycardia
9. Three-year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration
10. Cardiomyopathy in childhood, mitochondrial dysfunction, and the role of L-carnitine
11. The role of L-carnitine in paediatric cardiomyopathy